FlocaRx SRL
FlocaRx reported total assets of 690,403 € at the end of the 2025 financial year (annual accounts filed with the NBB on 12 Jun 2026).
The score of FlocaRx shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +94 % Total assets +6 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
FlocaRx's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 388,676 € | ||||
| Equity | 391,676 € | ||||
| Cash | 400,887 € | ||||
| EBITDA | 568,878 € | ||||
| Total assets | 690,403 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 Jun 2026
- Year ended 31 Dec 2024filed on 12 Jun 2025
- Year ended 31 Dec 2023filed on 11 Jun 2024
- Year ended 31 Dec 2022filed on 15 Jun 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
FlocaRx's financial analysis
- Solvency56.7%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of FlocaRx
FlocaRx's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0760.942.531
- VAT number
- BE0760942531
- Peppol
- Registered · 0208:0760942531 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Jan 2021
- Registered office
- 2650 Edegem
- Latest accounts
- 2025 · filed on 12 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
FlocaRx (SRL) has been based in Edegem since 2021, active in: medical specialists activities. For 2025, it reports a net profit of 388,676 € and equity of 391,676 €; its revenue is not published. Its solvency stands at 56.7%, below the median of its sector (72.2%).
Companies similar to FlocaRx
Companies in the same business, of comparable size and area, outside its group.
- Dr. Sandrine Beeckman, anesthesie en urgentiegeneeskunde Medical specialists activities Antwerp · balance sheet 690,769 €
- Sneyers Diest · balance sheet 689,829 €
- Lightning Star Properties Buying and selling of own real estate Antwerp · balance sheet 690,997 €
- Ferrimo Rental and operating of own or leased real estate Antwerp · balance sheet 691,076 €
- Dr. SACHA MIGNON MEDISCHE ONCOLOGIE Medical specialists activities Antwerp · balance sheet 691,079 €
- Vermeulen P. Woluwe-Saint-Pierre · balance sheet 690,350 €
- Scelles DU Mont DE Mainvault Ath · balance sheet 690,228 €
- Groot Eiland 34 Brussels · balance sheet 690,775 €
Frequently asked questions about FlocaRx
What is the revenue of FlocaRx?
FlocaRx files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of FlocaRx?
In Belgium, the VAT number is the company number prefixed with BE: BE0760942531 for FlocaRx, if the company is VAT-registered. Its company number (CBE) is 0760.942.531.
Where is the registered office of FlocaRx?
According to the CBE register, the registered office of FlocaRx is in 2650 Edegem.
What is the equity of FlocaRx?
At the close of the 2025 financial year, the equity of FlocaRx amounts to 391,676 €, a solvency of 56.7% of total assets.
Who manages FlocaRx?
The register lists 1 active mandates at FlocaRx. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of FlocaRx
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →